You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 29, 2026

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
Published on: April 27, 2011
Mariaelena Pierobon1, Claudio Belluco, Lance A Liotta
1Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.
This study highlights phosphorylated proteins as key players in cancer signaling. Reverse phase protein microarrays enable personalized cancer therapy by mapping patient-specific signaling pathways.
06:01Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
Published on: January 7, 2019
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: